| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.508 | 35.881 | 41.807 | 25.756 | 22.996 | 1.019 | 3.035 | 1.020 | 509 | - |
| Total Income - EUR | 49.508 | 35.881 | 41.807 | 25.758 | 22.996 | 1.019 | 3.035 | 1.020 | 509 | - |
| Total Expenses - EUR | 47.706 | 32.671 | 37.873 | 24.176 | 21.861 | 2.322 | 2.086 | 88 | 66 | - |
| Gross Profit/Loss - EUR | 1.802 | 3.209 | 3.934 | 1.582 | 1.135 | -1.302 | 950 | 932 | 443 | - |
| Net Profit/Loss - EUR | 1.510 | 2.133 | 2.777 | 1.324 | 762 | -1.333 | 859 | 902 | 372 | - |
| Employees | 4 | 4 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Imunocons Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.699 | 5.839 | 5.740 | 5.634 | 4.290 | 2.067 | 0 | 0 | 0 | - |
| Current Assets | 13.855 | 8.453 | 8.556 | 2.717 | 502 | 2.676 | 5.497 | 6.439 | 6.796 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 1.375 | 1.344 | 0 | 0 | - |
| Receivables | 12.284 | 6.903 | 6.682 | 1.711 | 305 | 299 | 0 | 5.209 | 5.193 | - |
| Cash | 1.570 | 1.550 | 1.874 | 1.007 | 196 | 1.002 | 4.153 | 1.230 | 1.603 | - |
| Shareholders Funds | -596 | 1.543 | 4.294 | 5.540 | 6.194 | 4.744 | 5.497 | 6.417 | 6.769 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 21.149 | 12.748 | 10.002 | 5.167 | -1.402 | 0 | 0 | 22 | 27 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Imunocons Srl